Sapitinib

Sapitinib is an erbB receptor tyrosine kinase inhibitor with potential antineoplastic activity. erbB kinase inhibitor AZD8931 binds to and inhibits erbB tyrosine receptor kinases, which may result in the inhibition of cellular proliferation and angiogenesis in tumors expressing erbB. The erbB protein family, also called the epidermal growth factor receptor (EGFR) family, plays major roles in tumor cell proliferation and tumor vascularization. The directory classifies it as a clinical API with a synthetic source/manufacturing origin. Other names for this substance include sapitinibum. Its PubChem CID is 11488320.

CAS No 848942-61-0
Molecular Formula C23H25ClFN5O3
Molecular Weight 473.9 g/mol
Synonyms 2-[4-[4-(3-chloro-2-fluoroanilino)-7-methoxyquinazolin-6-yl]oxypiperidin-1-yl]-N-methylacetamide

Frequently Asked Questions